Whole-Body MRI could spot hidden breast cancer spread sooner
NCT ID NCT06328465
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a special whole-body MRI scan can find breast cancer that has come back or spread to other parts of the body earlier than standard methods. Researchers will follow 145 women with aggressive breast cancer types (HER2+ or triple-negative) for five years to see if early detection improves survival. The goal is to see if this scan helps doctors treat recurrences more effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Diffusion whole body MRI (diagnostic test)
- What this could lead to
- If successful, this could show that regular whole-body MRI scans help catch breast cancer recurrences earlier, potentially leading to better treatment and longer survival for high-risk patients.
- What could go wrong
- This is a relatively small, early-stage study (145 people) without a comparison group, so results may not be conclusive. The MRI might find false alarms or not improve survival as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-POSITIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
European Institute of Oncology
RECRUITINGMilan, 20141, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can sound waves replace the scalpel for breast tumors?
- Can a High-Fiber diet shield the gut during breast cancer therapy?
- Can a triple drug combo shrink HER2-Positive breast tumors before surgery?
- Can an extra radiation dose keep HER2+ breast cancer at bay?
- Can mapping tumor DNA unlock personalized breast cancer care?